A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Ibrutinib in Healthy Participants
Clinical trial NCT01626651 · COMPLETED
Trial details
- NCT number
- NCT01626651
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2012-08-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.